SomInaClust

SomInaClust identifies cancer driver genes by analyzing somatic mutation patterns across tumor samples to distinguish oncogenes from tumor suppressor genes.

Key Features:

• Mutation pattern analysis: Distinguishes oncogenes by clustering of recurrent mutations at specific positions and tumor suppressor genes by enrichment of protein-truncating mutations distributed across the gene.
• Classification of driver genes: Classifies candidate driver genes as oncogenes or tumor suppressor genes based on their mutation pattern signatures.
• High sensitivity for rare mutations: Detects rare driver mutations occurring in less than 1% of samples and complements other driver-detection methods.
• Cross-cancer validation: Demonstrated performance across nine different solid cancer types.
• Pathway enrichment support: Uses pathway enrichment analysis to confirm that identified genes are part of known cancer signaling pathways.
• Research applications: Facilitates detection of candidate driver genes and filtering of somatic mutation data for downstream integrative analyses.

Scientific Applications:

• Driver gene identification: Detection of candidate cancer driver genes from somatic mutation data.
• Oncogene versus tumor suppressor classification: Categorization of genes based on clustering of recurrent mutations or enrichment of protein-truncating mutations.
• Rare variant discovery: Identification of driver mutations present in under 1% of samples.
• Cross-cancer analysis: Comparative analysis and validation of driver genes across multiple solid tumor types (nine cancers).
• Pathway-level interpretation: Assessment of biological relevance through pathway enrichment analysis.
• Data filtering for integrative studies: Prioritization and filtering of somatic mutation lists for downstream integrative analyses.

Methodology:

Analyzes somatic mutation patterns across tumor samples, identifies clustering of mutations for oncogenes and enrichment of protein-truncating mutations across gene length for tumor suppressors, classifies genes based on these patterns, and applies pathway enrichment analysis to assess biological relevance.